TY  - JOUR

T1  - Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)

JO  - Diabetes, Obesity and Metabolism

UR  - http://eprints.whiterose.ac.uk/154320/

PY  - 2019/07/01

AU  - Pollock RF

AU  - Heller S

AU  - Pieber TR

AU  - Woo V

AU  - Gundgaard J

AU  - Hallén N

AU  - Luckevich M

AU  - Tutkunkardas D

AU  - Zinman B

ED  - 

DO  - DOI: 10.1111/dom.13730

PB  - Wiley

VL  - 21

IS  - 7

SP  - 1706

EP  - 1714

Y2  - 2024/10/22

ER  -